Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Collins

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
American Journal of Human Genetics|October 4, 2014
Ascertainment bias causes false signal of anticipation in genetic prion diseaseEric Vallabh Minikel, Inga Zerr, Steven J Collins, et al.
Blood|November 2, 2006
MEK blockade converts AML differentiating response to retinoids into extensive apoptosisMichele Milella, Marina Konopleva, Cristina M Precupanu, et al.
Alzheimer'S Research & Therapy|April 17, 2021
Core Alzheimer's disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methodsJames D Doecke, Cindy Francois, Christopher J Fowler, et al.
Molecular Cancer Therapeutics|October 16, 2004
Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemiasMarina Konopleva, Elena Elstner, Teresa J McQueen, et al.
Nature Medicine|February 1, 2011
Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversionRyuichiro Atarashi, Katsuya Satoh, Kazunori Sano, et al.
Brain Research|March 6, 2003
Diverse fibrillar peptides directly bind the Alzheimer's amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulationAnthony R White, Fran Maher, Marcus W Brazier, et al.
Neurology|March 8, 2019
ATN profiles among cognitively normal individuals and longitudinal cognitive outcomesAnja Soldan, Corinne Pettigrew, Anne M Fagan, et al.
Viruses|September 28, 2021
Characterization of Prion Disease Associated with a Two-Octapeptide Repeat InsertionNicholas Brennecke, Ignazio Cali, Tze How Mok, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 30, 2022
Plasma p-tau181/Aβ<sub>1-42</sub> ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ<sub>1-42</sub> and future cognitive declineChristopher J Fowler, Erik Stoops, Stephanie R Rainey-Smith, et al.
JCI Insight|March 5, 2019
Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancerAdrian P Wiegmans, Jodi M Saunus, Sunyoung Ham, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
American Journal of Human Genetics|October 4, 2014
Ascertainment bias causes false signal of anticipation in genetic prion diseaseEric Vallabh Minikel, Inga Zerr, Steven J Collins, et al.
Blood|November 2, 2006
MEK blockade converts AML differentiating response to retinoids into extensive apoptosisMichele Milella, Marina Konopleva, Cristina M Precupanu, et al.
Alzheimer'S Research & Therapy|April 17, 2021
Core Alzheimer's disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methodsJames D Doecke, Cindy Francois, Christopher J Fowler, et al.
Molecular Cancer Therapeutics|October 16, 2004
Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemiasMarina Konopleva, Elena Elstner, Teresa J McQueen, et al.
Nature Medicine|February 1, 2011
Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversionRyuichiro Atarashi, Katsuya Satoh, Kazunori Sano, et al.
Brain Research|March 6, 2003
Diverse fibrillar peptides directly bind the Alzheimer's amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulationAnthony R White, Fran Maher, Marcus W Brazier, et al.
Neurology|March 8, 2019
ATN profiles among cognitively normal individuals and longitudinal cognitive outcomesAnja Soldan, Corinne Pettigrew, Anne M Fagan, et al.
Viruses|September 28, 2021
Characterization of Prion Disease Associated with a Two-Octapeptide Repeat InsertionNicholas Brennecke, Ignazio Cali, Tze How Mok, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 30, 2022
Plasma p-tau181/Aβ<sub>1-42</sub> ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ<sub>1-42</sub> and future cognitive declineChristopher J Fowler, Erik Stoops, Stephanie R Rainey-Smith, et al.
JCI Insight|March 5, 2019
Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancerAdrian P Wiegmans, Jodi M Saunus, Sunyoung Ham, et al.
Pageof 13